Arbutus Biopharma (ABUS) Earnings
|
Expand Research on ABUS
| Next EPS Date | 7/30/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +475.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/30/26  |
Q226 | N/A | -$0.03 | N/A | N/A | $650K | N/A | N/A | N/A | ||
| 5/7/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 5/5/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 5/4/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.04 | N/A | N/A | $400K | N/A | N/A | N/A | ||
| 5/13/26 |
Q126 | $0.87 | -$0.04 | +$0.91 | $179.23M | $400K | N/A |  | | Details | |
| 3/9/26 |
Q425 | N/A | -$0.03 | N/A | N/A | $776.33K | N/A | N/A | N/A |
